Dilemma of managing asymptomatic children referred with 'culture-confirmed' drug-resistant tuberculosis. Issue 7 (4th April 2016)

• Record Type: Journal Article
• Authors: Loveday, Marian; Sunkari, Babu; Marais, Ben J; Master, Iqbal; Brust, James C M
• Is Part Of: Archives of disease in childhood. Volume 101:Issue 7(2016)
• Page Start: 608
• Page End: 613
• Publication Date: 2016-04-04
• Subjects: DR-TB -- children -- Asymptomatic -- management -- HIV; Children -- Diseases -- Periodicals; Infants -- Diseases -- Periodicals; 618.920005
• DOI: 10.1136/archdischild-2015-310186
• Languages: English
• ISSNs: 0003-9888

Abstract

Abstract : Background: The diagnosis of drug-resistant tuberculosis (DR-TB) in children is challenging and treatment is associated with many adverse effects. Objective: We aimed to assess if careful observation, without initiation of second-line treatment, is safe in asymptomatic children referred with 'culture-confirmed' DR-TB. Setting: KwaZulu-Natal, South Africa—an area with high burdens of HIV, TB and DR-TB. Design, intervention and main outcome measures: We performed an outcome review of children with 'culture-confirmed' DR-TB who were not initiated on second-line TB treatment, as they were asymptomatic with normal chest radiographs on examination at our specialist referral hospital. Children were followed up every other month for the first year, with a final outcome assessment at the end of the study. Results: In total, 43 asymptomatic children with normal chest radiographs were reviewed. The median length of follow-up until final evaluation was 549 days (IQR 259–722 days); most (34; 83%) children were HIV uninfected. Resistance patterns included 9 (21%) monoresistant and 34 (79%) multidrug-resistant (MDR) strains. Fifteen children (35%) had been treated with first-line TB treatment, prior to presentation at our referral hospital. At the final evaluation, 34 (80%) children were well, 7 (16%) were lost to follow-up, 1 (2%) received MDR-TB treatment and 1 (2%) died of unknown causes. The child who received MDR-TB treatment developed new symptoms at the 12-month review and responded well to second-line treatment. Conclusions: Bacteriological evaluation should not be performed in the absence of any clinical indication. If drug-resistant Mycobacterium tuberculosis is detected in an asymptomatic child with a normal chest radiograph, close observation may be an appropriate strategy, especially in settings where potential laboratory error and poor record keeping are constant challenges.